Several big countries and pharmaceutical companies are caught up in the race to produce vaccines against the dreaded coronavirus, which is showing no signs of slowing down a year after it was first detected. This report delves into people’s opinions as they deal with the stress and fear of the virus that continues to impact their surroundings. Government agencies can leverage this data in their public outreach efforts.  

The new mutant strain first identified in the UK and now reported across several countries has raised fresh concerns and fears about the pandemic taking a turn for the worse. More so, as mass vaccinations for the original strain have not even begun in most parts of the world. The unprecedented situation that we faced earlier this year resulted in vaccines being developed, manufactured, and approved in record time, but not without raising questions and doubts about their safety and efficacy. As the country continues to grapple with rising cases, how trusting are Americans of the vaccine, as well as their country’s authorities? Piplsay polled 30,302 people nationwide to get the insights. Here is a summary of what we found:

Other Insights

• 59% of men are ‘completely convinced’ about getting a vaccine as compared to 41% of women
• 28% of Gen Zers are sure to get a vaccine as compared to 37% of millennials and 35% of Gen Xers
• 33% of women and 28% of men are ‘extremely worried’ about the vaccines’ safety and efficacy

Survey Methodology: This Piplsay survey (powered by Market Cube) was conducted nationwide in the US from December 26-28, 2020. We received 30,302 online responses from individuals aged 18 years and older.